HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.

Abstract
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), (n-3) fatty acids from fish oil, have immune-modulating effects and may improve nutritional status in cancer. The objective of this study was to investigate the effects of an oral nutritional supplement containing (n-3) fatty acids on nutritional status and inflammatory markers in patients with non-small cell lung cancer (NSCLC) undergoing multimodality treatment. In a double-blind experiment, 40 patients with stage III NSCLC were randomly assigned to receive 2 cans/d of a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids (2.0 g EPA + 0.9 g DHA/d) or an isocaloric control supplement. EPA in plasma phospholipids, energy intake, resting energy expenditure (REE), body weight, fat free mass (FFM), mid-upper arm circumference (MUAC), and inflammatory markers were assessed. Effects of intervention were analyzed by generalized estimating equations and expressed as regression coefficients (B). The intervention group (I) had a better weight maintenance than the control (C) group after 2 and 4 wk (B = 1.3 and 1.7 kg, respectively; P < 0.05), a better FFM maintenance after 3 and 5 wk (B = 1.5 and 1.9 kg, respectively; P < 0.05), a reduced REE (B = -16.7% of predicted; P = 0.01) after 3 wk, and a trend for a greater MUAC (B = 9.1; P = 0.06) and lower interleukin-6 production (B = -27.9; P = 0.08) after 5 wk. After 4 wk, the I group had a higher energy and protein intake than the C group (B = 2456 kJ/24 h, P = 0.03 and B = 25.0 g, P = 0.01, respectively). In conclusion, a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids beneficially affects nutritional status during multimodality treatment in patients with NSCLC.
AuthorsBarbara S van der Meij, Jacqueline A E Langius, Egbert F Smit, Marieke D Spreeuwenberg, B Mary E von Blomberg, Annemieke C Heijboer, Marinus A Paul, Paul A M van Leeuwen
JournalThe Journal of nutrition (J Nutr) Vol. 140 Issue 10 Pg. 1774-80 (Oct 2010) ISSN: 1541-6100 [Electronic] United States
PMID20739445 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Dietary Proteins
  • Fatty Acids, Omega-3
  • Phospholipids
  • Placebos
  • Eicosapentaenoic Acid
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Carcinoma, Non-Small-Cell Lung (therapy)
  • Combined Modality Therapy
  • Dietary Proteins (administration & dosage)
  • Dietary Supplements
  • Double-Blind Method
  • Eicosapentaenoic Acid (blood)
  • Energy Intake
  • Energy Metabolism
  • Fatty Acids, Omega-3 (administration & dosage)
  • Female
  • Humans
  • Inflammation (blood)
  • Lung Neoplasms (therapy)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nutritional Status (drug effects)
  • Patient Compliance
  • Phospholipids (blood)
  • Placebos

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: